Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
20.90
+0.60 (2.96%)
At close: Mar 27, 2026
HKG:2591 Revenue
In the year 2025, Guangzhou Innogen Pharmaceutical Group had annual revenue of 131.51M CNY. Guangzhou Innogen Pharmaceutical Group had revenue of 37.53M in the quarter ending December 31, 2025.
Revenue
131.51M CNY
Revenue Growth
n/a
P/S Ratio
65.24
Revenue / Employee
1.25M CNY
Employees
105
Market Cap
9.55B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 131.51M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition